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The canonical bacteriophage is obligately lytic: the virus infects a bacterium and hijacks cell functions to
produce large numbers of new viral particles which burst from the cell. Viruses of this type are well-studied,
but there exist a wide range of coexisting virus lifestyles that are less well understood. Temperate viruses
exhibit both a lytic cycle and a latent (lysogenic) cycle, in which viral genomes are integrated into the
bacterial host. Meanwhile, chronic (persistent) viruses use cell functions to produce more viruses without
killing the cell; chronic viruses may also exhibit a latent stage in addition to the productive stage. Here,
we use a mathematical model and experimental data from Pseudomonas aeruginosa to study the ecology of
these competing viral strategies. Understanding the ecology of P. aeruginosa and its phages is critical to
controlling bacterial infections in humans, especially when bacteria are resistant to antibiotics. Our analysis
reveals the conditions under which certain antibiotics can be effectively used in synergy with naturally
occurring phages to treat P. aeruginosa infections in immunocompromised humans, as well as the conditions
under which phages and antibiotics act antagonistically during infection control.
